Zeleciment rostudirsen (z-rostudirsen)

Name: Zeleciment rostudirsen (z-rostudirsen) in Duchenne muscular dystrophy: Incidence of Duchenne muscular dystrophy
Published: 2026-09-14T15:39:06-04:00

Duchenne muscular dystrophy

Also known as DYNE-251

Manufacturer: Dyne Therapeutics
Regulatory submission: BLA submitted May 2026
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description Epidemiology

Incidence of Duchenne muscular dystrophy

1 evidence topic · 1 source

Global birth prevalence

“the pooled global DMD birth prevalence was 19.8 (95% CI:16.6-23.6) per 100,000 live male births.” (opens the source at this quote in a new tab)